Cargando…
Improved Completion Rates and Characterization of Drug Reactions with an Intensive Chagas Disease Treatment Program in Rural Bolivia
BACKGROUND: Chagas disease treatment is limited by drug availability, adverse side effect profiles of available medications, and poor adherence. METHODS: Adult Chagas disease patients initiating 60-days of benznidazole were randomized to weekly or twice-weekly evaluations of medication adherence and...
Autores principales: | Tornheim, Jeffrey A., Lozano Beltran, Daniel F., Gilman, Robert H., Castellon, Mario, Solano Mercado, Marco A., Sullca, Walter, Torrico, Faustino, Bern, Caryn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777865/ https://www.ncbi.nlm.nih.gov/pubmed/24069472 http://dx.doi.org/10.1371/journal.pntd.0002407 |
Ejemplares similares
-
Characterization of digestive disorders of patients with chronic Chagas disease in Cochabamba, Bolivia
por: Pinto, Jimy-Jose, et al.
Publicado: (2019) -
Evaluation of Microscopic Observation Drug Susceptibility (MODS) and the string test for rapid diagnosis of pulmonary tuberculosis in HIV/AIDS patients in Bolivia
por: Lora, Meredith H., et al.
Publicado: (2015) -
Achievements and Challenges upon the Implementation of a Program for National Control of Congenital Chagas in Bolivia: Results 2004–2009
por: Alonso-Vega, Cristina, et al.
Publicado: (2013) -
Genetic association study of NLRP1, CARD, and CASP1 inflammasome genes with chronic Chagas cardiomyopathy among Trypanosoma cruzi seropositive patients in Bolivia
por: Clipman, Steven J., et al.
Publicado: (2018) -
Multi-criteria decision analysis approach for strategy scale-up with application to Chagas disease management in Bolivia
por: Pinazo, Maria-Jesus, et al.
Publicado: (2021)